Nassif David W. Insider Trades

Insider Trading History

Track insider trading activity for Nassif David W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pharvaris NV
Pharvaris NV PHVS
CFO / CLO
Holding Value $3.81M 120,300 shares
Last Trade
May 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$303k 10,000 shares
$30.31
$31.63
Pharvaris NV
Pharvaris NV PHVS
CFO / CLO
Holding Value $3.92M 123,925 shares
Last Trade
Mar 18, 2026 Sale
$11.1M 425,000 shares
$26.17
$31.63
Sio Gene Therapies
Sio Gene Therapies SIOX
Interim Ceo, CFO
Holding Value $261k 546,500 shares
Last Trade
Feb 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 546,500 shares
$0.77
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Chief Financial Officer
Holding Value $16.8k 35,066 shares
Last Trade
Dec 08, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$26.1k 17,534 shares
$1.49
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Chief Financial Officer
Holding Value $21.6k 45,244 shares
Last Trade
Dec 08, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.94k 6,294 shares
$1.42
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Chief Financial Officer
Holding Value $24.6k 51,538 shares
Last Trade
Dec 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.1k 17,534 shares
$1.49
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Chief Financial Officer
Holding Value $114k 239,000 shares
Last Trade
Apr 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$590k 239,000 shares
$2.47
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 22, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$39.5k 15,060 shares
$2.62
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Chief Financial Officer
Holding Value $16.3k 34,004 shares
Last Trade
Mar 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 15,060 shares
$2.62
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Principal Financial Officer
Holding Value $7.2k 15,060 shares
Last Trade
Jun 12, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$49.8k 15,060 shares
$3.31
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Principal Financial Officer
Holding Value $11.6k 24,210 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 15,060 shares
$3.21
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Principal Financial Officer
Holding Value $9.06k 18,944 shares
Last Trade
Jun 11, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.1k 5,266 shares
$3.25
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Principal Financial Officer
Holding Value $37.7k 78,900 shares
Last Trade
Apr 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 78,900 shares
$3.45
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Principal Financial Officer
Holding Value $14.4k 30,120 shares
Last Trade
Sep 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 30,120 shares
$7.77
$0.48
Sio Gene Therapies
Sio Gene Therapies SIOX
Principal Financial Officer
Holding Value $71.7k 150,000 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.44M 225,000 shares
$6.42
$0.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up